-+ 0.00%
-+ 0.00%
-+ 0.00%

Belite Bio Q4 2024 GAAP EPS $(0.32) Misses $(0.31) Estimate, As Of December 31, 2024, The Company Had $31.7M In Cash

Benzinga·03/17/2025 10:02:24
Listen to the news
Belite Bio (NASDAQ:BLTE) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.31) by 3.23 percent. This is a 28 percent decrease over losses of $(0.25) per share from the same period last year.